Your session is about to expire
← Back to Search
UAB30 for Non-Melanoma Skin Cancer
Study Summary
This trial is testing a new drug, UAB30, to see if it can help reduce the risk of skin cancer in people who have a history of the disease. The study will last for five years and will compare the effects of UAB30 to a placebo.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a serious illness or condition that is not under control, like an ongoing infection or heart problems, or if you have a situation that would make it hard to follow the study rules. If you have depression, the doctor will decide if you can take part in the study.You have at least 8 actinic keratoses, as confirmed by the study dermatologists or someone qualified to do so.You have had allergic reactions to drugs similar to retinoids.You cannot be taking medication to lower your cholesterol.You should be able to perform everyday activities without any help or only need a little help.You need to have normal blood cell counts, liver and kidney function, and normal levels of certain substances in your blood.If you had cancer within the last 5 years (except for certain types of skin cancer), you cannot join the study.
- Group 1: Renal Transplant subjects receiving UAB30
- Group 2: Renal Transplant subjects receiving placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are currently included in this research endeavor?
"Affirmative. Clinicaltrials.gov shows that this clinical trial, which was introduced to the public on October 1st 2020, is actively accepting participants. 84 individuals need to be recruited from a single location for the study's completion."
Are any new participants being enrolled in this investigation?
"Correct. The entry on clinicaltrials.gov confirms that this medical study, initially posted in October 2020, is recruiting patients. Eighty-four individuals need to be enrolled at a single site."
Share this study with friends
Copy Link
Messenger